FR2341311B1 - - Google Patents

Info

Publication number
FR2341311B1
FR2341311B1 FR7604825A FR7604825A FR2341311B1 FR 2341311 B1 FR2341311 B1 FR 2341311B1 FR 7604825 A FR7604825 A FR 7604825A FR 7604825 A FR7604825 A FR 7604825A FR 2341311 B1 FR2341311 B1 FR 2341311B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7604825A
Other languages
French (fr)
Other versions
FR2341311A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parcor SARL
Original Assignee
Parcor SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor SARL filed Critical Parcor SARL
Priority to FR7604825A priority Critical patent/FR2341311A1/fr
Priority to IE268/77A priority patent/IE44696B1/en
Priority to BE174953A priority patent/BE851461A/xx
Priority to NL7701666A priority patent/NL7701666A/xx
Priority to LU76787A priority patent/LU76787A1/xx
Priority to GB6976/77A priority patent/GB1533954A/en
Priority to DE19772707135 priority patent/DE2707135A1/de
Priority to DK69777A priority patent/DK146509C/da
Priority to ES456048A priority patent/ES456048A1/es
Priority to JP52017634A priority patent/JPS6042792B2/ja
Publication of FR2341311A1 publication Critical patent/FR2341311A1/fr
Application granted granted Critical
Publication of FR2341311B1 publication Critical patent/FR2341311B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7604825A 1976-02-20 1976-02-20 Derives de la pyridoxine Granted FR2341311A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR7604825A FR2341311A1 (fr) 1976-02-20 1976-02-20 Derives de la pyridoxine
IE268/77A IE44696B1 (en) 1976-02-20 1977-02-09 Pyrodoxine derivatives
BE174953A BE851461A (fr) 1976-02-20 1977-02-16 Derives de la pyridoxine
LU76787A LU76787A1 (da) 1976-02-20 1977-02-17
NL7701666A NL7701666A (nl) 1976-02-20 1977-02-17 Werkwijze voor het bereiden van een geneesmid- del, zo gevormd geneesmiddel en werkwijze ter bereiding van geschikte geneeskrachtige ver- bindingen.
GB6976/77A GB1533954A (en) 1976-02-20 1977-02-18 Pyridoxine derivatives
DE19772707135 DE2707135A1 (de) 1976-02-20 1977-02-18 Pyridoxinderivate, verfahren zu deren herstellung und dieselben enthaltendes mittel
DK69777A DK146509C (da) 1976-02-20 1977-02-18 Analogifremgangsmaade til fremstilling af pyridoxinderivater
ES456048A ES456048A1 (es) 1976-02-20 1977-02-18 Procedimiento de preparacion de derivados de la piridoxina.
JP52017634A JPS6042792B2 (ja) 1976-02-20 1977-02-19 ピリドキシン誘導体及びその製法並びに医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7604825A FR2341311A1 (fr) 1976-02-20 1976-02-20 Derives de la pyridoxine

Publications (2)

Publication Number Publication Date
FR2341311A1 FR2341311A1 (fr) 1977-09-16
FR2341311B1 true FR2341311B1 (da) 1979-10-05

Family

ID=9169423

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7604825A Granted FR2341311A1 (fr) 1976-02-20 1976-02-20 Derives de la pyridoxine

Country Status (10)

Country Link
JP (1) JPS6042792B2 (da)
BE (1) BE851461A (da)
DE (1) DE2707135A1 (da)
DK (1) DK146509C (da)
ES (1) ES456048A1 (da)
FR (1) FR2341311A1 (da)
GB (1) GB1533954A (da)
IE (1) IE44696B1 (da)
LU (1) LU76787A1 (da)
NL (1) NL7701666A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2428640A1 (fr) * 1978-06-12 1980-01-11 Parcor Derives de pyridoxine, leur procede de preparation et leur application therapeutique
JPH0515517U (ja) * 1991-07-31 1993-02-26 日本電気株式会社 一次放射器取付け構造
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
WO2024084056A1 (en) * 2022-10-21 2024-04-25 Etherna Immunotherapies Nv Ionizable lipids

Also Published As

Publication number Publication date
JPS52122375A (en) 1977-10-14
BE851461A (fr) 1977-08-16
IE44696B1 (en) 1982-02-24
NL7701666A (nl) 1977-08-23
DK146509C (da) 1984-04-02
JPS6042792B2 (ja) 1985-09-25
FR2341311A1 (fr) 1977-09-16
LU76787A1 (da) 1977-07-06
ES456048A1 (es) 1978-02-16
DK69777A (da) 1977-08-21
DK146509B (da) 1983-10-24
IE44696L (en) 1977-08-20
GB1533954A (en) 1978-11-29
DE2707135A1 (de) 1977-08-25

Similar Documents

Publication Publication Date Title
FR2343870B2 (da)
FR2355028B3 (da)
DK142413C (da)
FR2369072B1 (da)
FR2341311B1 (da)
DE2741501C3 (da)
DE2649125C2 (da)
JPS5417836B2 (da)
JPS52144691U (da)
DK153976A (da)
JPS5374801U (da)
JPS5518062Y2 (da)
DK141028C (da)
FR2353538B1 (da)
JPS5415497Y2 (da)
DE2655124C2 (da)
JPS5540454Y2 (da)
DK141448C (da)
JPS5443775B2 (da)
JPS52104223U (da)
JPS52155804U (da)
JPS52170673U (da)
CS177442B1 (da)
DD124808A1 (da)
DD124426A1 (da)

Legal Events

Date Code Title Description
ST Notification of lapse